In contrast to the above reports, Huang et al. [17], showed no statistically significant difference in mean CD4 count, weight change, WHO clinical staging, and opportunistic infections between the intervention and control groups among both treatment-naïve and treatment-experienced patients. The gene discussed is CD4; the disease is Opportunistic infection.